IL-3 promoted a rapid induction of sST2 already after 2 hours of stimulation, whereas ST2L became detectable after approximately 8 hours (Physique 1B). peripheral blood cells. Only upon CD3/CD28-ligation, IL-33 weakly enhances Th2 cytokine expression by in vivo polarized Th2 cells. This study on primary human cells demonstrates that basophils and eosinophils are the only direct target Mouse monoclonal to CD59(PE) leukocytes for IL-33, suggesting that IL-33 promotes allergic inflammation and Th2 polarization mainly by the selective activation of these specialized cells of the innate immune system. == Introduction == Cytokines of the interleukin (IL)1 family are major pro-inflammatory and immunoregulatory mediators that act through receptors of the Toll-like/IL-1-receptor (TLR/IL-1R) superfamily. Due to homologous intracellular Toll/interleukin-1 receptor (TIR) domains, IL-1 family members and TLR-ligands activate very similar signaling pathways leading to NF-B- and MAPK-activation. 1IL-1 and IL-1, the prototypic family members, are generated in response to exogenous and endogenous danger signals and act as chief inflammatory mediators in many inflammatory conditions.2Recent studies indicate that IL-1 may also participate in inflammatory pathologies and auto-immune diseases involving Th17-type T-helper cells.35By contrast, IL-18 is best known for its role in Th1-type immune responses because it strongly amplifies IFN- production in natural killer (NK) cells and Th1 cells in synergy with IL-12.2However, several lines of evidence mainly derived from mouse models indicate that IL-18 can also play a role in allergic diseases and defense against helminths.6,7For example, in the absence of IFN- signaling, IL-18 increases immunoglobulin E (IgE) levels and promotes a Th2-type pathology.8It has been suggested that this is due to the antigen-independent action of IL-18 on cells of the innate allergic response, basophils and mast cells.7Bone marrow-derived c-Kit/FcRI+mouse basophil-like cells express IL-18 receptors (IL-18R), and IL-18 induces IL-4 and IL-13 expression in an antigen-independent manner as efficiently as IL-3.8In the human system, IL-18 primes basophilic KU812 cells for enhanced leukotriene C4(LTC4) production.9Furthermore, a recent screen of novel CD antigens revealed that blood basophils express IL-18R and IL-18R-accessory Etifoxine hydrochloride protein (IL-18Rap),10indicating that IL-18 may also act on human basophils. A soluble form Etifoxine hydrochloride of an IL-1R family member ST2 (sST2; also called T1) has been cloned many years ago. sST2 is usually formed by many cells and increased sST2 levels are found in inflammatory conditions, including allergic asthma.1113The expression of transmembrane ST2-receptor (ST2L), however, is largely restricted to cells of hematopoietic origin. ST2L is expressed by mouse bone marrow-derived mast cells (BMMCs) and Etifoxine hydrochloride is a stable marker of mouse, but not human, Th2-lymphocytes.1417In the absence of a known ligand, the biologic roles of ST2 have been extensively studied in several mouse models using ST2-antibodies, sST2-constructs, and ST2-KO-mice.14,18Although the interpretations were sometimes conflicting, most studies indicate an important contribution of ST2 in Th2-type immune responses and allergic inflammation. The biology of ST2 is usually further complicated by a possible direct antiinflammatory action of Etifoxine hydrochloride sST2, and by the Etifoxine hydrochloride fact that this TIR domain name of ST2L appears to be a negative regulator of IL-1 and TLR signaling.19,20Research on ST2 strongly gained momentum by the recent discovery of its ligand, the novel IL-1 family member IL-33.21Like IL-1, the human IL-33 precursor (proIL-33) is a nuclear protein and was first identified as a gene (termedNF-HEV) differentially expressed by high endothelial venules of lymphatic tissues.22,23Like IL-1 and IL-18, human and mouse proIL-33 can be cleaved by caspase-1, at least in vitro. Infusion of IL-33 in mice leads to increased IL-4, IL-5 and IL-13 expression, high IgE levels, eosinophilia, and mucosal pathologies in vivo,21,24even in the absence of an adaptive immune system. After binding to ST2 and recruitment of the IL-1Rap as accessory receptors, IL-33 activates the classical TIR/IRAK signaling pathway.21,24,25It induces the production of proinflammatory cytokines and IL-13 in mouse BMMCs, and enhances the release of anti-CD3/CD28-induced IL-5 and IL-13 (but not IL-4) by in vitro polarized Th2 cell lines.21,2427 Only little is known about the biology of IL-33 and ST2 in the human system. A role of IL-33 in human allergic diseases is usually suggested.
VIP Receptors